Citadel Embolization Device Study

Primary Investigator
B
Bradley N. Bohnstedt, MD

Primary Investigator

Administratively Closed
18 years - 80 years
All
Phase N/A
150 participants needed
1 Location

Brief description of study

The purpose of this study is to gather preliminary safety and effectiveness data on Citadelbolization Device in the treatment of wide-neck intracranial aneurysms.

Detailed description of study

In this study, use of the Citadel Embolization Device will be limited to a population ofwith unruptured or ruptured wide-neck aneurysms who meet all study eligibility. The Citadel Embolization Device is intended to endovascularly obstruct or occlude blood flow in intracranial aneurysms.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Unruptured Wide-neck Aneurysms
  • Age: 18 years - 80 years
  • Gender: All

Inclusion Criteria:
  1. Has a single, unruptured or ruptured target intracranial aneurysm that is suitable fordovascular treatment.
Exclusion Criteria:
1.Target aneurysm has been previously treated

Updated on 26 Jan 2026. Study ID: SNEU-STRYKER-CITADEL, CDM10001448, 13720

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the Study Team